⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2306970 | 0.81 | HMGCR (0.32) | — | |
| SCHEMBL3827004 | 0.79 | — | — | |
| SCHEMBL1063211 | 0.79 | — | — | |
| SCHEMBL27509282 | 0.79 | — | — | |
| SCHEMBL28869957 | 0.79 | — | — | |
| SCHEMBL769720 | 0.78 | DGAT1 (0.44) | — | |
| SCHEMBL14152581 | 0.77 | DGAT1 (0.48) | — | |
| SCHEMBL17801117 | 0.77 | DGAT1 (0.44) | — | |
| SCHEMBL3940490 | 0.77 | DGAT1 (0.39) | — | |
| SCHEMBL16057010 | 0.77 | DGAT1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100540476-C | Method for recovering methacrylic acid from dilute aqueous methacrylic acid solution by reverse osmosis | ARKEMA (FR) | 2009-09-16 | — | — | CN | claimed |
| CN-1750996-A | A process for the recovery of methacrylic acid from its aqueous diluted solutions by reverse osmosis | ARKEMA (FR) | 2006-03-22 | — | — | CN | claimed |
| US-9340493-B2 | Hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-9340493-B2 | Hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-9340493-B2 | Hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-20150050227-A1 | Compositions Having Perspiration Reduction Properties | AMCOL INTERNATIONAL CORPORATION | 2015-02-19 | — | — | US | disclosed |
| US-20140206651-A1 | Hydroxamic Acid Derivatives Useful As Antibacterial Agents | PFIZER INC. (US) | 2014-07-24 | — | — | US | disclosed |
| US-20140206651-A1 | Hydroxamic Acid Derivatives Useful As Antibacterial Agents | PFIZER INC. (US) | 2014-07-24 | — | — | US | disclosed |
| US-20140206651-A1 | Hydroxamic Acid Derivatives Useful As Antibacterial Agents | PFIZER INC. (US) | 2014-07-24 | — | — | US | disclosed |
| US-8722686-B2 | Hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2014-05-13 | — | — | US | disclosed |
| US-8722686-B2 | Hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2014-05-13 | — | — | US | disclosed |
| WO-2010032147-A2 | HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| US-7186854-B2 | Process for making bicalutamide and intermediates thereof | SYNTHON IP INC. (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186854-B2 | Process for making bicalutamide and intermediates thereof | SYNTHON IP INC. (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186854-B2 | Process for making bicalutamide and intermediates thereof | SYNTHON IP INC. (US) | 2007-03-06 | — | — | US | disclosed |
| EP-1546093-A1 | PROCESS FOR MAKING BICALUTAMIDE AND INTERMEDIATES THEREOF | Synthon B.V. (NL) | 2005-06-29 | — | — | EP | disclosed |
| US-6818766-B2 | USING P-FLUOROBENZENESULFINIC ACID | SYNTHON BV (NL) | 2004-11-16 | — | — | US | disclosed |
| WO-2004031136-A1 | PROCESS FOR MAKING BICALUTAMIDE AND INTERMEDIATES THEREOF | SYNTHON B.V. (NL) | 2004-04-15 | — | — | WO | disclosed |
| US-20040068135-A1 | Process for making bicalutamide and intermediates thereof | SYNTHON IP INC. | 2004-04-08 | — | — | US | disclosed |
| US-20030073742-A1 | Process for making bicalutamide and intermediates thereof | SYNTHON B.V. (NL) | 2003-04-17 | — | — | US | disclosed |